SGS Life Science Services Opens Paris Lab

June 18, 2015

SGS Life Science Services announced the opening of its new bio/pharmaceutical quality control laboratory at Villeneuve La Garenne, a Paris suburb, replacing an existing facility in Clichy.

Opening June 29, 2015, the state-of-the-art laboratory will incorporate best-in-class infrastructure and equipment to meet the current and future demands of its bio/pharmaceutical clients. This multi-million Euro investment will serve the French market, support biologics development, and will operate under Good Manufacturing Practice.

The 2,100-square-meter facility has been designed and built for the needs of the pharmaceutical industry, targeting the reduction of sample processing times through increased operational efficiency. All services currently available in Clichy will be transferred to Villeneuve La Garenne, with a special emphasis on safety equipment (fume hoods) to effectively treat organic products and classified carcinogenic, mutagenic, reprotoxic (CMR) substances. At the new site, SGS will introduce services to address the growing biopharmaceutical pipeline with capabilities for mycoplasma tests and amino acid analysis.

The contamination of cell cultures by mycoplasma is a major risk for the biopharmaceutical industry. By their diversity, their small size and lack of bacterial wall, these microorganisms are not detectable visually, are very difficult to remove and can compromise the quality of biologic medicines. To meet the needs of its customers, SGS has created a new Mycoplasma detection department.